Search Within

Mark Andrew Dickson

Formats
  1. Journal Article (86)
  2. Meeting Abstract (84)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Department of Medicine (172)
  2. Sarcoma Service (172)
  3. Solid Tumor Oncology Division (172)
  4. GSK Faculty (94)
  5. Hematologic Malignancies, Division of (89)
  6. Tow Center for Developmental Oncology (TCDO) (80)

More Groups

People
  1. William Tap (92)
  2. Sandra D'Angelo (85)
  3. Mary Keohan (77)
  4. Mrinal Gounder (71)
  5. Li-Xuan Qin (58)
  6. Ping Chi (56)

More People

Years
  1. 2025 (6)
  2. 2024 (13)
  3. 2023 (13)
  4. 2022 (19)
  5. 2021 (6)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (74)
  2. Clinical Cancer Research (17)
  3. Annals of Oncology (8)
  4. European Journal of Cancer (5)
  5. Nature Communications (5)
  6. The Oncologist (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. American Association for Cancer Research (20)
  3. Elsevier Inc. (14)
  4. Oxford University Press (13)
  5. Nature Publishing Group (10)
  6. Springer (6)

More Publishers

Results (172)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Expanding the molecular diversity of CIC-rearranged sarcomas with novel and very rare partners
    Journal Article

    Linos, K.; Dermawan, J. K.; Bale, T.; Rosenblum, M. K.; Singer, S.; Tap, W.; Dickson, M. A.; Hornick, J. L.; Antonescu, C. R.
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma
    Research Letter

    Gu, L.; Lin, E.; Liu, S.; Yang, N.; Kurtansky, N.; Neumann, N. M.; Stoll, J.; Lezcano, C.; Pulitzer, M.; Noor, S.; more...
    Journal of Medical Virology (2023)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Thornton, K. A.; Movva, S.; Nacev, B. A.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Nacev, B. A.; Rosenbaum, E.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Presence of immune infiltrates, increased expression of transposable elements, and viral response pathways in sarcoma associate with response to checkpoint inhibition
    Meeting Abstract

    Nacev, B. A.; Bradic, M.; Richards, A. L.; Kelly, C. M.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Chi, P.; Movva, S.; Thornton, K. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The emerging fifth epidemiologic subtype of Kaposi sarcoma in HIV-negative men who have sex with men at a tertiary care center in NYC from 2000 to 2021
    Meeting Abstract

    Morales, A. E.; Benson, G.; Glavan, S.; Giuliano, R.; Dickson, M. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • nab-Sirolimus for patients with advanced malignant PEComa with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program
    Meeting Abstract

    Dickson, M. A.; Ravi, V.; Riedel, R. F.; Ganjoo, K. N.; Van Tine, B. A.; Chugh, R.; Cranmer, L. D.; Gordon, E. M.; Chen, J. L.; Murphy, M. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Selinexor in advanced, metastatic dedifferentiated liposarcoma: A multinational, randomized, double-blind, placebo-controlled trial
    Journal Article

    Gounder, M. M.; Razak, A. A.; Somaiah, N.; Chawla, S.; Martin-Broto, J.; Grignani, G.; Schuetze, S. M.; Vincenzi, B.; Wagner, A. J.; Chmielowski, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save